Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
08/2005
08/18/2005US20050181359 Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
08/18/2005US20050180992 Fabricating wet spun or electrospun fibers using nanometer scale liquid crystalline viral particle suspensions where particle composition and function can be modified genetically to include binding or nucleating conjugate moieties while maintaining fibrous structure end product
08/18/2005DE102004004043A1 Reinigung von hochmolekularen Verbindungen mittels Affinitätsmembranchromatographie Purification of high molecular weight compounds by means of affinity membrane chromatography
08/17/2005EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease
08/17/2005EP1563834A1 Hollow nanoparticles of protein and drug using the same
08/17/2005EP1407006B1 Method for the recovery and purification of poxviruses from infected cells
08/17/2005EP1066372B1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same
08/17/2005EP0636172B1 Genetically engineered attenuated viruses
08/17/2005CN2717963Y Ultra high-pressure virus inactivating device
08/17/2005CN1655827A Novel use of adenoviruses and nucleic acids coding therefor
08/17/2005CN1654665A Attenuated vaccinia virus Tiantan strain vector and its preparation and application
08/17/2005CN1654658A Combined application of gp64 gene and p35 gene of baculovirus
08/17/2005CN1654638A Method for constructing weak strain of plant virus
08/17/2005CN1654637A Interferential RNA retrovirus and its preparation and use
08/17/2005CN1215082C Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
08/16/2005US6929941 Chimeric cell-targeting pathogenic organism and method of therapeutic use
08/16/2005US6929798 Compositions and methods for treatment of microbial infections
08/16/2005CA2224257C Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
08/16/2005CA2086936C Method for producing members of specific binding pairs
08/11/2005WO2005072364A2 A modified baculovirus expression system for production of pseudotyped raav vector
08/11/2005WO2005072214A2 Improved inactivated fcv vaccines
08/11/2005WO2005072129A2 Production of host cells containing mutiple integrating vectors by serial transduction
08/11/2005WO2004057021A3 Molecular methods and compositions for detecting and quantifying respiratory viruses
08/11/2005WO2003088899A3 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
08/11/2005US20050176146 Using vector transformation to generate heat resistant viral particles
08/11/2005US20050176130 Functional mutations in respiratory syncytial virus
08/11/2005US20050176129 Adenovirus vector
08/11/2005US20050176128 Method for assembling subunits into capsoids
08/11/2005US20050175991 Using fluid comprising bacteria lysing virus bacteria as tool in cleaning fruits and vegatables
08/11/2005US20050175985 Cold-adapted equine influenza viruses
08/11/2005US20050175633 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
08/11/2005US20050175632 Vaccine for preventing cervical cancer
08/11/2005US20050175594 Myoviridae; also used to treat animals infected with Listeria monocytogenes
08/11/2005US20050175589 Anti-neoplastic viral agents
08/11/2005CA2553989A1 Production of host cells containing mutiple integrating vectors by serial transduction
08/11/2005CA2553805A1 Improved inactivated feline calicivirus vaccines
08/11/2005CA2548992A1 Immunotherapy compositions, method of making and method of use thereof
08/10/2005EP1561819A1 Method of transferring gene into t cells
08/10/2005EP1561817A2 Modified CEA and uses thereof
08/10/2005EP1561758A1 Method for isolating and purifying viruses from plant sources
08/10/2005EP1560491A2 Bacteriophage having modified holin and uses thereof
08/10/2005EP1336088B1 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium
08/10/2005EP0597852B2 Swine pneumonia vaccine and method for the preparation thereof
08/10/2005CN1653184A Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
08/10/2005CN1653183A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
08/10/2005CN1653182A Recombinant fowlpox virus
08/10/2005CN1653181A Expression of genes in modified vaccinia virus ankara by using the cowpox ATI promoter
08/10/2005CN1653176A Compositions and methods for generating an immune response
08/10/2005CN1653172A Cotton rat lung cells for virus culture
08/10/2005CN1652819A Attenuation of metapneumovirus
08/10/2005CN1651573A New Aike 30 Virus and its use
08/10/2005CN1651457A Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens
08/04/2005WO2005071093A2 Chimpanzee adenovirus vaccine carriers
08/04/2005WO2005071085A1 Process for producing virus vector
08/04/2005WO2005071084A1 Construction of gutted recombinant adenovirus effectively expressing antibodies comprising human constant region and uses thereof
08/04/2005WO2005071069A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
08/04/2005WO2005071068A1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS
08/04/2005WO2005070953A1 Purification of high-molecular compounds by means of affinity membrane chromatography
08/04/2005WO2005070454A2 A novel process of hepatitis a vaccine preparation
08/04/2005WO2005001059A3 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
08/04/2005WO2004092360A3 The severe acute respiratory syndrome coronavirus
08/04/2005US20050172357 Insect viruses and their uses in protecting plants
08/04/2005US20050172343 Astrocyte modulated genes and uses thereof
08/04/2005US20050170336 Using genetic engineering to prepare virus having plurality of recognition sites for selective binding or nucleating; synthesis of trifunctionalized viral particles for use as field effect transistors
08/04/2005US20050169939 Produced in cultured cells without Marek's disease contamination
08/04/2005US20050169890 Recombinant vector; overexpresses an adenovirus death protein (ADP), is replication-restricted to neoplastic cells expressing telomerase
08/04/2005CA2554198A1 Process for producing virus vector
08/04/2005CA2553756A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
08/04/2005CA2553541A1 Chimpanzee adenovirus vaccine carriers
08/04/2005CA2547757A1 Monoparamunity inducers based on attenuated rabbit myxoma viruses
08/03/2005EP1558726A1 Vaccines against west nile virus
08/03/2005EP1558724A2 Organellar targeting of rna and its use in the interruption of environmental gene flow
08/03/2005EP1558643A2 T cell receptor display
08/03/2005EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
08/03/2005EP0742834B2 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
08/03/2005EP0702719B1 Process for the sterilization of biological compositions and the product produced thereby
08/03/2005CN1650021A Stable adenoviral vectors and methods for propagation thereof
08/03/2005CN1648260A Use of SARS coronary virus ORF8 region
08/03/2005CN1648254A Goose parvo-virus VP1 and VP3 gene non-overlapping sequence pronucleus expression protein and its preparing method
08/03/2005CN1213068C Improvments in or relating to immune responses to HIV
08/02/2005US6924144 Method and means for producing high titer, safe, recombinant lentivirus vectors
08/02/2005US6924137 virus is propagated in culture media at a cultivation temperature below 37 degrees C., wherein the chordopoxvirus is selected from Avipoxvirus and modified vaccinia virus Ankara
08/02/2005US6924095 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
08/02/2005US6923971 Vaccines
08/02/2005US6923970 Retrovirus-like particles made non-infectious by a plurality of mutations
08/02/2005US6923969 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine
07/2005
07/28/2005WO2005068639A2 Particle-induced ghrelin immune response
07/28/2005WO2005067643A2 Determination of hepatitis c virus genotype
07/28/2005WO2005067543A2 Murine calicivirus
07/28/2005WO2005067506A2 Method for monitoring and generating high capacity gutless adenoviral vector
07/28/2005WO2005067478A2 Recombinant icosahedral virus like particle production in pseudomonads
07/28/2005WO2005051433B1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent
07/28/2005US20050166287 Mag1 nucleic acid molecules and their uses
07/28/2005US20050166286 Use of naturally occurring antimicrobial polypeptides isolated from insects induced with plant pathogens; genetic engineering; fungicide
07/28/2005US20050164941 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens
07/28/2005US20050164940 Fus6 family antimicrobial polypeptides and their uses
07/28/2005US20050164939 Nucleotide sequences coding polypeptide associated with the generation of disease resistant plants
07/28/2005US20050164392 Expression vector comprising adenoviral regulatory sequences for use as tool in enhancement of heterologous gene transfer and viral expression in cells
07/28/2005US20050164344 Metabotropic glutamate receptor regulator for use in identifying modulator of channel-mediated intracellular calcium mobilization and treatment of nervous system disorders
07/28/2005US20050164175 Respiratory Syncytial Virus; vectors containing heterogeneity genes